People
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two to three months.
Pharma veteran Michael Varney, Genentech’s head of Research and Development, will retire from the company at the end of July after spending 15 years with the company.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
AMO Pharma, a British biopharmaceutical company, is targeting a pathway most often associated with cancer to treat people with genetic encephalopathy.
One day after Moderna announced its COVID-19 vaccine candidate has moved into Phase II testing, Chief Executive Officer Stéphane Bancel laid out the bad news – if it works, there won’t be enough of the vaccine to be quickly distributed across the globe.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The actual death toll for COVID-19 won’t be calculable for some time, but there are early indications that it may be significantly lower than calculations of deaths per confirmed cases lead one to believe.
Ansun Pharmaceuticals used its influenza research data to dive into attempts to develop a treatment for COVID-19. DAS181 is it’s potential candidate for COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 7, 2020.
PRESS RELEASES
